Hantavirus Pulmonary Syndrome , Southern Chile, 1995–2012 - Volume 21, Number 4—April 2015 - Emerging Infectious Disease journal - CDC
Volume 21, Number 4—April 2015
Synopsis
Hantavirus Pulmonary Syndrome , Southern Chile, 1995–2012
On This Page
Raúl Riquelme, María Luisa Rioseco, Lorena Bastidas, Daniela Trincado, Mauricio Riquelme, Hugo Loyola, and Francisca Valdivieso
Abstract
Hantavirus is endemic to the Region de Los Lagos in southern Chile; its incidence is 8.5 times higher in the communes of the Andean area than in the rest of the region. We analyzed the epidemiologic aspects of the 103 cases diagnosed by serology and the clinical aspects of 80 hospitalized patients during 1995–2012. Cases in this region clearly predominated during winter, whereas in the rest of the country, they occur mostly during summer. Mild, moderate, and severe disease was observed, and the case-fatality rate was 32%. Shock caused death in 75% of those cases; high respiratory frequency and elevated creatinine plasma level were independent factors associated with death. Early clinical suspicion, especially in rural areas, should prompt urgent transfer to a hospital with an intensive care unit and might help decrease the high case-fatality rate.
Since the first cases described in United States in 1993, hantavirus pulmonary syndrome (HPS) has been reported in the United States, Argentina, Bolivia, Brazil, Chile, Ecuador, Paraguay, Panama, Uruguay, and Venezuela (1). Several types of New World hantaviruses (family Bunyaviridae) have been recognized. Their distribution is determined by the density of rodent populations serving as specific reservoirs of each virus type.
In Chile, Andes virus is the only identified hantavirus (2). It was first reported in 1995 during an outbreak in Argentina and is carried by the murid rodent Oligoryzomyslongicaudatus (i.e., long-tailed mouse or “colilargo”) in southern Argentina and central and southern Chile (3).
In Chile, where HPS is subject to immediate mandatory reporting to health authorities, a total of 786 cases occurred during 1995–2012. Regional and seasonal incidences varied from 0.17 to 0.53 cases per 100,000 inhabitants (4). Despite such low incidence, HPS is of public health concern because of its severity and its high case-fatality rate (CFR) (20%–60%).
We examined the clinical and epidemiologic features of HPS during 17 years in the provinces of Llanquihue and Palena, which had the highest incidences of this disease in Chile. This geographic area is served by the Health Service of Reloncaví (HSR) in Puerto Montt city, which has its 420-bed reference center at the Hospital of Puerto Montt in Puerto Montt.
Dr. RaúlRiquelme is associated professor of internal medicine and respiratory diseases in the School of Medicine, San SebastianUniversity, Hospital de Puerto Montt, Chile. His primary research interests are community-acquired pneumonia and hantavirus disease.
Acknowledgment
We thank Roberto Murua for his valuables comments. We also thank Carolina Larrain for assistance in manuscript editing. We greatly appreciate the technical assistance of Marcela Amtmann.
References
- Centers for Disease Control and Prevention. International HPS cases [cited 2013 Feb 1].http://www.cdc.gov/hantavirus/surveillance/international.html
- Medina RA. Torres-PerezF, GalenoH, NavarreteM, VialPA, PalmaRE, et al.Ecology, genetic diversity, and phylogeographic structure of andes virus in humans and rodents in Chile.J Virol. 2009;83:2446–59.PubMed
- Centers for Disease Control and Prevention. Outbreak of acute illness—southwestern United States, 1993. MMWR Morb Mortal Wkly Rep.1993;42:421–4 .PubMed
- Ministerio de Salud. Gobierno de Chile. El Vigía. 2012;13(27).
- Fang GD, Fine M, Orloff J, Arisumi D. YuVL, KpoorW, et al.New emerging etiologies for community-acquired pneumonia with implications for therapy.Medicine. 1990;69:307–16.
- Riquelme R, Riquelme M, Torres A, Rioseco ML, Vergara JA, Scholz L, Hantavirus pulmonary syndrome, southern Chile. Emerg Infect Dis.2003;9:1438–43. DOIPubMed
- Instituto Nacional de Estadísticas. Censo 2002 [cited2013 Feb 1]. http://www.ine.cl/cd2002/
- Tapia M, Mansilla C, Vera J. Síndrome pulmonar por hantavirus: experiencia clínica en diagnóstico y tratamiento. Hospital Coyhaique-Chile. Rev Chilena Infectol. 2000;17:258–69. DOI
- Vial PA, Valdivieso F, Ferres M, Riquelme R, Rioseco ML, Calvo M, High-dose intravenous methylprednosolone for hantavirus cardiopulmonary syndrome in Chile: a double-blind, randomized controlled clinical trial. Clin Infect Dis. 2013;57:943–51. DOIPubMed
- Murúa R, Navarrete M, Cádiz R, Figueroa R, Padula P, Zaror L, Sindrome pulmonar por hantavirus: situación de los roedores reservorios y la población humana en la Decima Región de Chile. Rev Med Chil. 2003;131:169–76. DOIPubMed
- Murua R, Gonzalez L, Gonzalez M, Jofre C. Efectos del florecimiento del arbusto Chusquea quilaKunth (Poaceae) sobre la demografia de poblaciones de roedores de los bosques templados frios del sur chileno. Bol SocBiolConcepc. 1996;67:37–42.
- Gonzales Y, Gonzalez M. Memoria y saber cotidiano. El florecimiento de la “quila” en el sur de Chile: de pericotes, ruinas y remedios.Revista Austral de Ciencias Sociales.2006;10:75–102.
- Glass GE, Yates TL, Fine JB, Shields TM, Kendall JB, Hope AG, Satellite imagery characterizes local animal reservoir populations on Sin Nombre virus in the southwestern United States. Proc Natl Acad Sci U S A. 2002;99:16817–22. DOIPubMed
- MacNeilA. KsiasekT, RollinP. Hantavirus pulmonary syndrome, United States, 1993–2009. Emerg Infect Dis. 2011;17:1195–201 and.PubMed
- Martinez VP, Bellomo CM, Cacace ML, Suarez P, Bogni L, Padula PJ. Hantavirus pulmonary síndrome in Argentina, 1995–2008. Emerg Infect Dis.2010;16:1853–60. DOIPubMed
- Khan AS, Khabbaz RF, Armstrong LR, Holman RC, Bauer SP, Graber J, Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis.1996;173:1297–303. DOIPubMed
- Murua R. Ecología de los reservorios silvestres de hantavirus en Chile. Rev Chilena Infectol. 1998;15:79–83.
- Langlois JP, Fahrig L, Merriam G, Hartsob H. Landscape structure influences continental distribution of hantavirus in deer mice. Landscape Ecol.2001;16:255–66. DOI
- Murua R, Padula P. Ecología y evolución de hantavirus en el Cono Sur de América. Arch Med Vet. 2004;36:1–20. DOI
- Knust B, Rollin PE. Twenty-year summary of surveillance for human hantavirus infections, United States. Emerg Infect Dis. 2013;19:1934–7.DOIPubMed
- Castillo C, Naranjo J, Ossa G. Síndrome cardiopulmonar por hantavirus en 21 adultos en la IX región de Chile. Rev Chilena Infectol. 2000;17:241–7.DOI
- Castillo C, Naranjo J, Ossa G, Levi H. Hantavirus pulmonarysyndromedue to Andes virus in Temuco, Chile. Chest. 2001;120:548–54.DOIPubMed
- Baró M, Vergara J, Navarrete M. Hantavirus en Chile: revisión y análisis de casos desde 1975. Rev Med Chil. 1999;61:269–75.
- Krüger DH, Schönrich G, Klempa B. Human pathogenic hantaviruses and prevention of infection. Hum Vaccin. 2011;7:685–93. DOIPubMed
- Navarrete M, Barrera C, Zaror L, Otth C. Rapid immunochromatographic test for hantavirus andes contrasted with capture-IgM ELISA for detection of Andes-specific IgM antibodies. J Med Virol. 2007;79:41–4. DOIPubMed
Figures
Tables
Suggested citation for this article:Riquelme R, Rioseco ML, Bastidas L, Trincado D, Riquelme M, Loyola H, et al. Hantavirus pulmonary syndrome, southern Chile, 1995–2012. Emerg Infect Dis [Internet]. 2015 Apr [date cited]. http://dx.doi.org/10.3201/eid2104.141437
No hay comentarios:
Publicar un comentario